|
|
||||||||
Ann Thorac Surg 1989;47:799-805
© 1989 The Society of Thoracic Surgeons
Cardiothoracic Institute and National Heart Hospital, London, England
* Address reprint requests to Dr Bodnar, Cardiothoracic Institute, 76 Dovehouse St. London SW3 6LY, United Kingdom.
One hundred fifty-five freeze-dried, 63 frozen, and 337 Hanks'-antibiotic solution preserved or nutrient-antibiotic solution preserved homografts used for isolated aortic valve replacement have been followed for 1 to 20 years (mean, 5.3 years), a total of 2, 931 patient-years of follow-up information. Overall survival, valve-related death, primary tissue failure, failure due to surgical technical error, infective endocarditis, and overall eventfree survival have been assented and compared. Overall survival 20 years after operation was 51.6% ± 8.1% with a low incidence of sudden death. The method and length of preservation did not have any effect on the long-term performance or the mode of failure of the homografts. The rate of primary tissue failure was apparently higher with valves preserved in a solution containing calf serum, but the difference was not significant. It is concluded that long-term patient survival and quality of life after aortic valve replacement with a homograft are excellent. The current study, however, could not verify the existence of a significant difference between the three assessed methods of homograft preservation. Furthermore, it could not prove the importance of cellular viability or the existence of clinically significant immunological factors other than the calf serum content of the nutrient medium.
This article has been cited by other articles:
![]() |
T. Athanasiou, C. Jones, R. Jin, G. L. Grunkemeier, and D. N. Ross Homograft Implantation Techniques in the Aortic Position: To Preserve or Replace the Aortic Root? Ann. Thorac. Surg., May 1, 2006; 81(5): 1578 - 1585. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Aagaard and P. V. Andersen Acute endocarditis treated with radical debridement and implantation of mechanical or stented bioprosthetic devices Ann. Thorac. Surg., January 1, 2001; 71(1): 100 - 103. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Homann, J. C. Haehnel, N. Mendler, S. U. Paek, K. Holper, H. Meisner, and R. Lange Reconstruction of the RVOT with valved biological conduits: 25 years experience with allografts and xenografts Eur J Cardiothorac Surg, June 1, 2000; 17(6): 624 - 630. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Biberthaler, N. Mendler, U. Ettner, and H. Meisner Endothelial prostacyclin (PGI-2) production of human and porcine valve allografts related to ischemic history Eur J Cardiothorac Surg, November 1, 1998; 14(5): 503 - 507. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Hahn, S. K.C. Tam, G. J. Vlahakes, A. D. Hilgenberg, C. W. Akins, and M. J. Buckley Repeat aortic root replacement Ann. Thorac. Surg., July 1, 1998; 66(1): 88 - 91. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. C. Song, L. Y. Yao, J. M. Kneebone, and F. M. Lupinetti EFFECT OF CRYOPRESERVATION AND HISTOCOMPATIBILITY ON TYPE I PROCOLLAGEN GENE EXPRESSION IN AORTIC VALVE GRAFTS J. Thorac. Cardiovasc. Surg., September 1, 1997; 114(3): 421 - 427. [Abstract] [Full Text] |
||||
![]() |
R. C. Elkins, M. M. Lane, and C. McCue Pulmonary Autograft Reoperation: Incidence and Management Ann. Thorac. Surg., August 1, 1996; 62(2): 450 - 455. [Abstract] [Full Text] |
||||
![]() |
X. J. Feng, C. E. J. Van Hove, P. J. Walter, and A. G. Herman EFFECTS OF STORAGE TEMPERATURE AND FETAL CALF SERUM ON THE ENDOTHELIUM OF PORCINE AORTIC VALVES J. Thorac. Cardiovasc. Surg., January 1, 1996; 111(1): 218 - 230. [Abstract] [Full Text] |
||||
![]() |
T. M. Sundt III, N. Rasmi, K. Wong, R. Radley-Smith, A. Khaghani, and M. H. Yacoub Reoperative aortic valve operation after homograft root replacement: Surgical options and results Ann. Thorac. Surg., August 1, 1995; 60(suppl_2): S95 - S100. [Abstract] [PDF] |
||||
![]() |
M. Valante, G. Faggian, M. E. Billingham, E. Talenti, F. Calabrese, R. Casula, N. E. Shumway, and G. Thiene The aortic valve after heart transplantation Ann. Thorac. Surg., August 1, 1995; 60(suppl_2): S135 - S140. [Abstract] [PDF] |
||||
![]() |
O. M. Shapira, J. D. Fonger, K. Reardon, and R. J. Shemin Unexplained fever after aortic valve replacement with cryopreserved allografts Ann. Thorac. Surg., August 1, 1995; 60(suppl_2): S151 - S155. [Abstract] [PDF] |
||||
![]() |
M. G. Hazekamp, D. R. Koolbergen, J. Braun, H. Sugihara, C. J. Cornelisse, Y. A. Goffin, and H. A. Huysmans In situ hybridization: A new technique to determine the origin of fibroblasts in cryopreserved aortic homograft valve explants J. Thorac. Cardiovasc. Surg., July 1, 1995; 110(1): 248 - 257. [Abstract] [Full Text] |
||||
![]() |
J. P. Christy, F. M. Lupinetti, A. H. Mardan, and S. A. Thompson Endothelial cell viability in the rat aortic wall Ann. Thorac. Surg., February 1, 1991; 51(2): 204 - 207. [Abstract] [PDF] |
||||
![]() |
H. E. Khatib, S. A. Thompson, and F. M. Lupinetti Effect of storage at 4 {degrees}C in a nutrient medium on antigenic properties of rat aortic valve allografts Ann. Thorac. Surg., May 1, 1990; 49(5): 792 - 796. [Abstract] [PDF] |
||||
![]() |
N. E. Shumway About viability in valve grafts Ann. Thorac. Surg., June 1, 1989; 47(6): 795 - 795. [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |